ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36525
0.00%
Bitcoin
67,797.41
0.11%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. INVO BioScience Inc (INVO)

  7. INVO BioScience Inc (INVO) News

INVO

INVO BioScience (INVO)

INVO BioScience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INVO
DateTimeSourceHeadlineSymbolCompany
05/21/20243:39PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INVOINVO BioScience Inc
05/15/20243:51PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
05/15/20243:15PMGlobeNewswire Inc.INVO Reports Record First Quarter 2024 Financial ResultsNASDAQ:INVOINVO BioScience Inc
05/06/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
04/17/20249:25AMAllPennyStocks.comMicro Cap Massively Bid Up Before Opening BellNASDAQ:INVOINVO BioScience Inc
04/16/20243:59PMGlobeNewswire Inc.INVO Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:INVOINVO BioScience Inc
02/06/20249:24AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INVOINVO BioScience Inc
02/01/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
01/23/20247:00AMGlobeNewswire Inc.NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)NASDAQ:INVOINVO BioScience Inc
01/17/20247:00AMGlobeNewswire Inc.INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board DirectorsNASDAQ:INVOINVO BioScience Inc
01/16/20244:29PMEdgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:INVOINVO BioScience Inc
01/10/20243:46PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:INVOINVO BioScience Inc
01/10/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
01/03/20244:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
12/28/20234:04PMEdgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:INVOINVO BioScience Inc
12/28/20234:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
12/13/20234:08PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INVOINVO BioScience Inc
12/13/20233:53PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
12/11/20237:00AMPR Newswire (US)NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood JournalNASDAQ:INVOINVO BioScience Inc
11/28/20234:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
11/28/20238:00AMPR Newswire (US)INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity RequirementNASDAQ:INVOINVO BioScience Inc
11/24/202312:08PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INVOINVO BioScience Inc
11/20/20233:59PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
11/13/20233:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
11/13/20233:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INVOINVO BioScience Inc
11/13/20233:01PMPR Newswire (US)INVO Reports Record Third Quarter 2023 Financial ResultsNASDAQ:INVOINVO BioScience Inc
11/13/20238:23AMEdgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:INVOINVO BioScience Inc
11/13/20238:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
11/13/20238:12AMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:INVOINVO BioScience Inc
11/10/20238:00AMPR Newswire (US)NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending MergerNASDAQ:INVOINVO BioScience Inc
 Showing the most relevant articles for your search:NASDAQ:INVO

Your Recent History

DBI
I2P8
IN XTK MSCI JAPCLITRSF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved